COVIDcast - Remdesivir (ACTT-1 trial)
We interrupt our normal FOAMcast episodes to bring you updates from COVID-19. *Our understanding of COVID-19 is rapidly developing and this may be out of date in days/weeks. So, check back for updates/fact check what you hear* This episode reviews the NIAID trial, ACTT-1, on remdesivir vs placebo (Beigel et al) Show notes: FOAMcast.org Thanks for listening, Lauren Westafer and Jeremy Faust *Recorded May 23, 2020
